Cullinan Therapeutics, Inc.

MARTINGALE ASSET MANAGEMENT L P CGEM

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/13/2026

Shares

61,938

Value ($000)

1,128

Weight

0.0%

2022 Q3 - 2026 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/13/2026	1,128	0.0%	61,938	6/30/2026
2025 Q2	8/11/2025	158	0.0%	20,932	6/30/2025
2025 Q1	5/14/2025	168	0.0%	22,132	3/31/2025
2024 Q4	2/13/2025	469	0.0%	38,545	12/31/2024
2024 Q3	11/14/2024	550	0.0%	32,842	9/30/2024
2024 Q2	8/12/2024	245	0.0%	14,022	6/30/2024
2024 Q1	5/14/2024	725	0.0%	42,529	3/31/2024
2023 Q4	2/12/2024	433	0.0%	42,529	12/31/2023
2023 Q3	11/14/2023	385	0.0%	42,529	9/30/2023
2023 Q2	8/11/2023	458	0.0%	42,529	6/30/2023
2023 Q1	5/12/2023	435	0.0%	42,529	3/31/2023
2022 Q4	2/13/2023	439	0.0%	41,629	12/31/2022
2022 Q3	11/14/2022	398	0.0%	31,016	9/30/2022